(NASDAQ: MASI) Masimo's forecast annual revenue growth rate of 5.39% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.63%.
Masimo's revenue in 2024 is $2,016,900,000.On average, 5 Wall Street analysts forecast MASI's revenue for 2024 to be $111,610,392,585, with the lowest MASI revenue forecast at $111,287,594,724, and the highest MASI revenue forecast at $112,032,349,182. On average, 5 Wall Street analysts forecast MASI's revenue for 2025 to be $118,440,535,719, with the lowest MASI revenue forecast at $117,878,671,677, and the highest MASI revenue forecast at $119,752,793,074.
In 2026, MASI is forecast to generate $125,661,355,763 in revenue, with the lowest revenue forecast at $124,751,691,390 and the highest revenue forecast at $127,165,227,801.